Watson Pharmaceuticals Income Statement
View: Annual | Quarterly
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 2,535.5 | 2,496.7 | 1,979.2 |
| Cost of Goods Sold | 1,502.8 | 1,504.8 | 1,233.5 |
| Gross Profit | 1,032.7 | 991.9 | 745.8 |
| Gross Profit Margin | 40.7% | 39.7% | 37.7% |
| SG&A Expense | 423.4 | 421.2 | 131.5 |
| Depreciation & Amortization | 80.7 | 176.4 | 163.7 |
| Operating Income | 386.5 | 268.8 | (388.9) |
| Operating Margin | 15.2% | 10.8% | -- |
| Nonoperating Income | 19.3 | 4.2 | 4.8 |
| Nonoperating Expenses | (19.1) | -- | -- |
| Income Before Taxes | 358.3 | 224.3 | (410.9) |
| Income Taxes | 119.9 | 83.3 | 34.1 |
| Net Income After Taxes | 238.4 | 141.0 | (445.0) |
| Continuing Operations | 238.4 | 141.0 | (445.0) |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 238.4 | 141.0 | (445.0) |
| Total Net Income | 238.4 | 141.0 | (445.0) |
| Net Profit Margin | 9.4% | 5.6% | -- |
| Diluted EPS from Total Net Income ($) | 2.09 | 1.27 | (4.37) |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
